Terms search
1
Antiphospholipid Syndrome: Current Research Highlights and Clinical Insights
Doruk Erkan; Michael D. Lockshin (eds.)
2
Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome
Lies Persijn; An-Sofie Decavele; Sofie Schouwers; Katrien Devreese
3
Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review
Artenjak; Andrej; Lakota; Katja; Frank; Mojca; Čučnik; Saša; Rozman; Blaž; Božič; Borut; Shoenfeld; Yehuda; Sodin-Semrl; Snezna
4
The inhibition of protein C anticoagulant activity by anti-β2-glycoprotein I (β2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods
M. Ieko; T. Nakabayashi; M. Takeda; S. Naitoh; T. Atsumi; T. Koike
5
Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays
Katrien M.J. Devreese; Frederik Van Hoecke
6
Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays
Akito Tsutsumi; Taichi Hayashi; Yusuke Chino; Mizuko Mamura; Daisuke Goto; Isao Matsumoto; Satoshi Ito; Takayuki Sumida
7
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)
V. Pengo; G. Denas; E. Bison; A. Banzato; S. Padayattil Jose; P. Gresele; F. Marongiu; N. Erba; F. Veschi; A. Ghirarduzzi; E. De Candia; B. Montaruli; M. Marietta; S. Testa; D. Barcellona; A. Tripodi
8
Prevalence of Anticardiolipin and Anti-β2-Glycoprotein I Antibodies in Celiac Disease
Sami Karoui; Maryam Kallel Sellami; Asma Belkhodja Laatar; Mondher Zitouni; Samira Matri; Lilia Laadhar; Monia Fekih; Jalel Boubaker; Sondes Makni; Azza Filali
9
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
Unlu; Ozan; Zuily; Stephane; Erkan; Doruk
10
New autoantigens in the antiphospholipid syndrome
Cristiano Alessandri; Fabrizio Conti; Monica Pendolino; Riccardo Mancini; Guido Valesini
11
Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome
Efthymiou; M.; Arachchillage; D.R.J.; Lane; P.J.; O'Keeffe; A.G.; McDonnell; T.; Cohen; H.; Mackie; I.J.
12
Clinical Thrombotic Manifestations in SLE Patients With and Without Antiphospholipid Antibodies: A 5-year Follow-up
Tunde Tarr; Gabriella Lakos; Harjit Pal Bhattoa; Pal Soltesz; Yehuda Shoenfeld; Gyula Szegedi; Emese Kiss
13
9. Immunology and Genetics
14
Antiphospholipid antibodies in rheumatoid arthritis: Identifying the dominoes
Debbie A. Gladd; Ewa Olech
15
Solid cancer, antiphospholipid antibodies, and venous thromboembolism
Carme Font; Laura Vidal; Gerard Espinosa; Dolors Tàssies; Joan Monteagudo; Blanca Farrús; Laura Visa; Ricard Cervera; Pere Gascon; Joan C. Reverter
16
Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy
A. Ruffatti; M. Tonello; A. Cavazzana; P. Bagatella; V. Pengo
17
Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms
Doruk Erkan; Gerard Espinosa; Ricard Cervera
18
Lung adenocarcinoma and antiphospholipid antibodies
Ernesto de Meis; Robson Q. Monteiro; Roger A. Levy
19
The association of anti-phospholipid antibodies with parity in placental malaria
S. Owens; L. W. Chamley; J. Ordi; B. J. Brabin; P. M. Johnson
20
Does seronegative antiphospholipid syndrome really exist
Ricard Cervera; Fabrizio Conti; Andrea Doria; Luca Iaccarino; Guido Valesini
21
Antibodies to oxidized LDL/β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism
V. Pengo; E. Bison; A. Ruffatti; S. Iliceto
22
Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine–prothrombin complex: Identical or distinct diagnostic tools for antiphospholipid syndrome
Troy D. Jaskowski; Andrew R. Wilson; Harry R. Hill; Ware D. Branch; Anne E. Tebo
23
Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren’s syndrome
Pasoto; Sandra Gofinet; Chakkour; Henrique Pires; Natalino; Renato Romera; Viana; Vilma S. T.; Bueno; Cleonice; Lianza; Alessandro Cavalcanti; Andrade; José Lázaro; Neto; Mauricio Levy; Fuller; Ricard
24
Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)
A. Banzato; N. Pozzi; R. Frasson; V. De Filippis; A. Ruffatti; E. Bison; S.J. Padayattil; G. Denas; V. Pengo
25
Maternal cardiolipin, β2-glycoprotein-I and prothrombin antibody expression in high-risk pregnancies with bilateral abnormal uterine artery Doppler waveforms
S. Donohoe; M. Geary; J. C. P. Kingdom; E. Jauniaux; G. Purdy; I. J. Mackie
26
Clinical significance of antiphosphatidylethanolamine antibodies in the so-called “seronegative antiphospholipid syndrome”
Marielle Sanmarco
27
Prévalence et Influence de l'Hypoparathyroïdie Fonctionnelle dans la Survenue de Fractures de Fragilité dans une Population de Femmes Ménopausées
A. Amouzougan; F. Chopin; B. Gerbay Meyrieux; E. Ollagnier; P. Collet; T. Thomas
28
Primary Anetoderma and Antiphospholipid Antibodies—Review of the Literature
Emmilia Hodak; Michael David
29
Rôle de l'OPG et du TRAIL dans la calcification vasculaire au cours de l'insuffisance rénale chronique
M. Chasseraud; A. Mozar; A. Caudrillier; L. Louvet; S. Liabeuf; R. Mentaverri; M. Brazier; Z. Massy; S. Kamel
30
Relation entre les anticorps antiphospholipides et les caractéristiques cliniques de la syndrome des antiphospholipides avec morbidité obstétricale
A. Cavazzana; A. Ruffatti; M. Tonello; M. Bortolati; S. Olivieri; V. Pengo; L. Punzi
31
L'induction pharmacologique de l'hème oxygenase-1 diminue la phase aigüe de l'arthrite
N. Tellier; M. Benallaoua; M. François; F. Batteux; J. Shyy; C. Fitting; L. Tsagris; J. Boczkowski; J.-F. Savouret; M.-T. Corvol; S. Poiraudeau; F. Rannou
32
Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies
Wenche Jy; Maike Tiede; Carlos J. Bidot; Lawrence L. Horstman; Joaquin J. Jimenez; Julio Chirinos; Yeon S. Ahn
33
Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature
Maria Bortolati; Piero Marson; Fabrizio Fabris; Vittorio Pengo; Myriam Facchinetti; Giustina De Silvestro; Amelia Ruffatti
34
Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome
Paul R.J. Ames; Maurizio Margaglione; Antonio Ciampa; Donatella Colaizzo; Felicetto Ferrara; Luigi Iannaccone; VincenzoBrancaccio
35
Role of an intronic polymorphism in thePDCD1gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies
Dharambir K. Sanghera; Susan Manzi; Franklin Bontempo; Cara Nestlerode; M. Ilyas Kamboh
36
Lipoprotein (a) and apolipoprotein (a) in primary antiphospholipid syndrome
Mirjana Bećarević; Sandra Singh; Nada Majkić-Singh
37
Targeted Treatment of the Rheumatic Diseases || Management of the Antiphospholipid Syndrome
Erkan; Doruk
38
Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations
Mazzoccoli; Carmela; Comitangelo; Domenico; DâIntrono; Alessia; Mastropierro; Valeria; Sabbà ; Carlo; Perrone; Antonio
39
High-sensitivity C-reactive protein: Discriminator between patients with primary and secondary antiphospholipid syndrome
Mirjana Bećarević; Nada Majkić-Singh
40
Antiphospholipid Syndrome and Cognition
Bernardo Liberato; Roger A. Levy
41
Additional laboratory tests to improve on the diagnosis of antiphospholipid syndrome
Tripodi; Armando
